Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lilly's Field Of Dreams: "Campaign For Modern Medicines" Wants A Clean PDUFA

Executive Summary

A pharma-sponsored group is actively pushing what many think may be an impossible task: passing the Prescription Drug User Fee reauthorization without any add-ons from Congress.

Related Content

PDUFA Word Association: Consumer Advocates Complain About Lack Of "Safety" In Commitment Letter
PDUFA V Commitment Letter Front-Loads Guidance, Meeting Milestones
PDUFA V Commitment Letter Front-Loads Guidance, Meeting Milestones
To Prevent Drug Shortages, Don't Look To Inspections, FDA Says
FDA, Industry Reach Agreement On Major Portions Of Generic User Fee Program
Conflict-Of-Interest Policy Relaxation For FDA Cmtes. Could Be Easy PDUFA Add-on
Not Another FDAAA – Observers Expect Fewer FDA Reforms In PDUFA V
What’s In A PDUFA Reauthorization? Maybe These Issues…
BIO’s "Big Ideas" For FDA Reform Are Too Big For PDUFA
Antibiotics Could Get Double Exclusivity Under House Bill; FDA Makes Its Own Moves





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts